Report

Global Regulatory Affairs Outsourcing Market Size study, by Services by Company Size by Category by Indication by Stage (Preclinical, Clinical, PMA ) by End-use and Regional Forecasts 2022-2028

  • Publish Date: Jun,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Regulatory Affairs Outsourcing Market, by Region, 2020-2028 (USD Billion)
1.2.2. Regulatory Affairs Outsourcing Market, by Services, 2020-2028 (USD Billion)
1.2.3. Regulatory Affairs Outsourcing Market, by Company Size, 2020-2028 (USD Billion)
1.2.4. Regulatory Affairs Outsourcing Market, by Category, 2020-2028 (USD Billion)
1.2.5. Regulatory Affairs Outsourcing Market, by Indication, 2020-2028 (USD Billion)
1.2.6. Regulatory Affairs Outsourcing Market, by Stage, 2020-2028 (USD Billion)
1.2.7. Regulatory Affairs Outsourcing Market, by End-use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Regulatory Affairs Outsourcing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Regulatory Affairs Outsourcing Market Dynamics
3.1. Regulatory Affairs Outsourcing Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Significant increase in the fixed costs of in-house resources for regulatory affairs & operation activities
3.1.1.2. Augmenting the volume of clinical trial applications and product registration
3.1.2. Market Challenges
3.1.2.1. Strict government regulations regarding the various medical products
3.1.3. Market Opportunities
3.1.3.1. Increase in geographical expansion activities by companies
3.1.3.2. Increase in R&D activities
Chapter 4. Global Regulatory Affairs Outsourcing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Regulatory Affairs Outsourcing Market, by Services
6.1. Market Snapshot
6.2. Global Regulatory Affairs Outsourcing Market by Services, Performance - Potential Analysis
6.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Services 2018-2028 (USD Billion)
6.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
6.4.1. Regulatory Consulting
6.4.2. Legal Representation
6.4.3. Regulatory Writing & Publishing
6.4.4. Product Registration & Clinical Trial Applications
6.4.5. Other Services
Chapter 7. Global Regulatory Affairs Outsourcing Market, by Company Size
7.1. Market Snapshot
7.2. Global Regulatory Affairs Outsourcing Market by Company Size, Performance - Potential Analysis
7.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Company Size 2018-2028 (USD Billion)
7.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
7.4.1. Small
7.4.2. Medium
7.4.3. Large
Chapter 8. Global Regulatory Affairs Outsourcing Market, by Category
8.1. Market Snapshot
8.2. Global Regulatory Affairs Outsourcing Market by Category, Performance - Potential Analysis
8.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Category 2018-2028 (USD Billion)
8.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
8.4.1. Drugs
8.4.2. Generics
8.4.3. Innovators
8.4.4. Biologics
8.4.5. Biotech
8.4.6. ATMPs
8.4.7. Biosimilars
8.4.8. Medical devices
8.4.9. Therapeutic
8.4.10. Diagnostic
Chapter 9. Global Regulatory Affairs Outsourcing Market, by Indication
9.1. Market Snapshot
9.2. Global Regulatory Affairs Outsourcing Market by Indication, Performance - Potential Analysis
9.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Indication 2018-2028 (USD Billion)
9.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
9.4.1. Oncology
9.4.2. Neurology
9.4.3. Cardiology
9.4.4. Immunology
9.4.5. Others
Chapter 10. Global Regulatory Affairs Outsourcing Market, by Stage
10.1. Market Snapshot
10.2. Global Regulatory Affairs Outsourcing Market by Stage, Performance - Potential Analysis
10.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Stage 2018-2028 (USD Billion)
10.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
10.4.1. Preclinical
10.4.2. Clinical
10.4.3. PMA (Post Market Authorization)
Chapter 11. Global Regulatory Affairs Outsourcing Market, by End-use
11.1. Market Snapshot
11.2. Global Regulatory Affairs Outsourcing Market by End-use, Performance - Potential Analysis
11.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by End-use 2018-2028 (USD Billion)
11.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
11.4.1. Medical Device Companies
11.4.2. Pharmaceutical Companies
11.4.3. Biotechnology Companies
Chapter 12. Global Regulatory Affairs Outsourcing Market, Regional Analysis
12.1. Regulatory Affairs Outsourcing Market, Regional Market Snapshot
12.2. North America Regulatory Affairs Outsourcing Market
12.2.1. U.S. Regulatory Affairs Outsourcing Market
12.2.1.1. Services breakdown estimates & forecasts, 2018-2028
12.2.1.2. Company Size breakdown estimates & forecasts, 2018-2028
12.2.1.3. Category breakdown estimates & forecasts, 2018-2028
12.2.1.4. Indication breakdown estimates & forecasts, 2018-2028
12.2.1.5. Stage breakdown estimates & forecasts, 2018-2028
12.2.1.6. End-use breakdown estimates & forecasts, 2018-2028
12.2.2. Canada Regulatory Affairs Outsourcing Market
12.3. Europe Regulatory Affairs Outsourcing Market Snapshot
12.3.1. U.K. Regulatory Affairs Outsourcing Market
12.3.2. Germany Regulatory Affairs Outsourcing Market
12.3.3. France Regulatory Affairs Outsourcing Market
12.3.4. Spain Regulatory Affairs Outsourcing Market
12.3.5. Italy Regulatory Affairs Outsourcing Market
12.3.6. Rest of Europe Regulatory Affairs Outsourcing Market
12.4. Asia-Pacific Regulatory Affairs Outsourcing Market Snapshot
12.4.1. China Regulatory Affairs Outsourcing Market
12.4.2. India Regulatory Affairs Outsourcing Market
12.4.3. Japan Regulatory Affairs Outsourcing Market
12.4.4. Australia Regulatory Affairs Outsourcing Market
12.4.5. South Korea Regulatory Affairs Outsourcing Market
12.4.6. Rest of Asia Pacific Regulatory Affairs Outsourcing Market
12.5. Latin America Regulatory Affairs Outsourcing Market Snapshot
12.5.1. Brazil Regulatory Affairs Outsourcing Market
12.5.2. Mexico Regulatory Affairs Outsourcing Market
12.6. Rest of The World Regulatory Affairs Outsourcing Market
Chapter 13. Competitive Intelligence
13.1. Top Market Strategies
13.2. Company Profiles
13.2.1. Accell Clinical Research, LLC
13.2.1.1. Key Information
13.2.1.2. Overview
13.2.1.3. Financial (Subject to Data Availability)
13.2.1.4. Company Size Summary
13.2.1.5. Recent Developments
13.2.2. GenPact Ltd.
13.2.3. Criterium, Inc.
13.2.4. PRA Health Sciences
13.2.5. Promedica International
13.2.6. Dr. Regenold GmbH
13.2.7. BioMapas
13.2.8. Zeincro Group
13.2.9. Parexel International Corp.
13.2.10. Charles River Laboratories International, Inc.
Chapter 14. Research Process
14.1. Research Process
14.1.1. Data Mining
14.1.2. Analysis
14.1.3. Market Estimation
14.1.4. Validation
14.1.5. Publishing
14.2. Research Attributes
14.3. Research Assumption